Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
Regeneron Pharmaceuticals (NASDAQ: REGN) has announced an updated presentation time for the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will now present at 7:00 a.m. ET on Monday, September 8, 2025.
The presentation will be accessible through a live webcast on Regeneron's investor relations website, with replays and transcripts remaining available for at least 30 days after the event.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha annunciato una nuova fascia oraria per la sua presentazione al Morgan Stanley 23rd Annual Global Healthcare Conference. L'intervento si terrà ora alle 7:00 ET di lunedì 8 settembre 2025.
La presentazione sarà disponibile in diretta streaming sul sito degli investor relations di Regeneron; le registrazioni e le trascrizioni resteranno accessibili per almeno 30 giorni dopo l'evento.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha anunciado un nuevo horario para su presentación en la Morgan Stanley 23rd Annual Global Healthcare Conference. La compañía presentará ahora a las 7:00 a.m. ET del lunes 8 de septiembre de 2025.
La presentación podrá seguirse mediante una retransmisión en vivo en la página de relaciones con inversores de Regeneron; las repeticiones y las transcripciones estarán disponibles durante al menos 30 días tras el evento.
Regeneron Pharmaceuticals (NASDAQ: REGN)가 Morgan Stanley 제23회 연례 글로벌 헬스케어 컨퍼런스의 발표 시간 변경을 발표했습니다. 발표는 이제 2025년 9월 8일 월요일 동부시간(ET) 오전 7:00에 진행됩니다.
발표는 Regeneron의 투자자 관계 웹사이트를 통해 실시간 웹캐스트로 시청할 수 있으며, 재방송 및 전사본은 행사 후 최소 30일간 제공됩니다.
Regeneron Pharmaceuticals (NASDAQ: REGN) a annoncé une modification de l'horaire de sa présentation à la Morgan Stanley 23rd Annual Global Healthcare Conference. La société présentera désormais à 7h00 ET le lundi 8 septembre 2025.
La présentation sera diffusée en direct via un webcast sur le site relations investisseurs de Regeneron ; les rediffusions et les transcriptions resteront disponibles pendant au moins 30 jours après l'événement.
Regeneron Pharmaceuticals (NASDAQ: REGN) hat eine neue Präsentationszeit für die Morgan Stanley 23rd Annual Global Healthcare Conference bekanntgegeben. Das Unternehmen wird nun am Montag, den 8. September 2025, um 7:00 Uhr ET präsentieren.
Die Präsentation ist über einen Live-Webcast auf der Investor-Relations-Website von Regeneron zugänglich; Wiedergaben und Transkripte stehen mindestens 30 Tage nach der Veranstaltung zur Verfügung.
- None.
- None.
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025.
The presentation will be webcast live and may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcast will be archived on the Company's website for at least 30 days.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com
FAQ
When is Regeneron (REGN) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Regeneron's Morgan Stanley conference presentation?
How long will Regeneron's conference presentation replay be available?
What is the updated time for REGN's Morgan Stanley conference presentation?
